Intellectual property (IP) is a crucial aspect of cancer research. Securing patents for new drugs, diagnostic tools, and treatment methods ensures that researchers and companies can protect their innovations and obtain financial returns. However, the process of obtaining and enforcing IP rights can be complex and contentious, often involving legal disputes and negotiations.
